Amita Patnaik

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Top Venues

Cancer research

Clinical cancer research : an official journal of the American Association for Cancer Research

Targeted oncology

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Dana Piovesan, Amber E de Groot, Soonweng Cho, Amy E Anderson, Rebecca D Ray, Amita Patnaik, Paul G Foster, Casey G Mitchell, Alejandra Y Lopez Espinoza, Wandi S Zhu, Carlo E Stagnaro, Hema Singh, Xiaoning Zhao, Lisa Seitz, Nigel P C Walker, Matthew J Walters, Kelsey E Sivick
Fc-Silent Anti-TIGIT Antibodies Potentiate Antitumor Immunity without Depleting Regulatory T Cells. Cancer research 84 (12) (2024)
Sarina A Piha-Paul, Shane A Olwill, Erika Paige Hamilton, Anthony W Tolcher, Paula R Pohlmann, Stephen V Liu, Cornelia Wurzenberger, Laura-Carolin Hasenkamp, Eva-Maria Hansbauer, Rachna T Shroff, Sara Alsterlind Hurvitz, Anuradha Krishnamurthy, Amita Patnaik, Noah M Hahn, Raman Kumar, Manuela Duerr, Markus Zettl, Kayti Aviano, Louis Matis, Ingmar Bruns, Geoffrey Y Ku
A First-in-Human Study of cinrebafusp alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Dana Piovesan, Amber E de Groot, Soonweng Cho, Amy E Anderson, Rebecca D Ray, Amita Patnaik, Paul G Foster, Casey G Mitchell, Alejandra Y Lopez Espinoza, Wandi S Zhu, Carlo E Stagnaro, Hema Singh, Xiaoning Zhao, Lisa Seitz, Nigel P C Walker, Matthew J Walters, Kelsey E Sivick
Fc-silent anti-TIGIT antibodies potentiate anti-tumor immunity without depleting regulatory T cells. Cancer research (2024)
David S Hong, Michael A Postow, Bartosz Chmielowski, Ryan J Sullivan, Amita Patnaik, Ezra E W Cohen, Geoffrey I Shapiro, Conor E Steuer, Martin Gutierrez, Heather Yeckes-Rodin, Robert Ilaria, Brenda C O'Connell, Joanna Peng, Guangbin Peng, Nora Zizlsperger, Anthony W Tolcher, Jedd D Wolchok
Eganelisib, a First-in-Class PI3K-γ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Amita Patnaik, Shirish Gadgeel, Kyriakos P Papadopoulos, Drew W Rasco, Naomi B Haas, Hirak Der-Torossian, Demiana Faltaos, Diane Potvin, Vanessa Tassell, Manal Tawashi, Richard Chao, Peter J O'Dwyer
Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors. Targeted oncology 17 (2) (2022)
Amita Patnaik, Glen J Weiss, Drew W Rasco, Lisa Blaydorn, Amy Mirabella, Murali Beeram, Wei Guo, Sharon Lu, Hadi Danaee, Kristen McEachern, Ellie Im, Jasgit C Sachdev
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial. Cancer chemotherapy and pharmacology (2021)